* Alimera Sciences Inc ALIM.OQ reported a quarterly
adjusted
loss of 59 cents per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 42 cents per share.
* Revenue rose 1.3% to $13.96 million from a year ago;
analysts
expected $13.41 million.
* Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 59 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Alimera Sciences Inc shares had fallen by 9.0% this
quarter.
* The company reported a quarterly loss of $4.11 million.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $14.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated February 24 at 03:17 p.m.
All figures in US dollars unless otherwise stated